European Pharmaceutical Review

NOVEMBER 1, 2023

He is an experienced biotech and technology industry executive with international experience in drug development, data science, sales and marketing, and business management. Bacterial vaccines in clinical and preclinical development 2021 [Internet]. 2019 Jan; 7(1): e58-e67. 2019 Oct 16;7(4):151. The Lancet.

Vaccines 115

Vaccines Immunity Immunization Drug Development 115

European Pharmaceutical Review

MARCH 11, 2024

For example, broadly neutralising antibodies (bNAbs), capsid inhibitors and maturation inhibitors all might play a role in fighting HIV from the initial binding and fusion of HIV into immune cells, to where it integrates into the cell, out to its assembly and maturation.

Immunization 98

Immunization Immunity Clinical Pharmacology Drug Development 98

pharmaphorum

JANUARY 13, 2022

Others include a partnership between Biogen and Sangamo and Eli Lilly’s $1 billion takeover of Prevail in 2020, as well as a now-defunct alliance between AbbVie and Voyager in 2019, based on gene therapy approaches to target the rogue protein.

Immunization 98

Immunization Immunity Vaccines Drug Development 98

PharmaShots

MARCH 14, 2023

The article focuses on challenges faced in drug development, government incentive programs, grants, and various therapies used to diagnose or treat rare diseases. How challenging is the drug development plan Drug development plans for rare diseases can be circuitous, resulting in fewer participation from companies.

Drug Development 40

Drug Development Immunization Immunity Compounding 40

PharmaShots

FEBRUARY 21, 2023

Nordic is advancing the development of CD37-targeted therapies for hematological cancers and immune diseases. The company is developing PPMX-T002, an anti-cancer drug with an antibody targeting CDH3 connected with a radioisotope yttrium 90 (90Y).

Dosage 56

Dosage Labelling Immunity Immunization 56

Pharmaceutical Technology

FEBRUARY 14, 2023

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.

Diabetes 40

Diabetes Immunization Immunity Vaccines 40

European Pharmaceutical Review

DECEMBER 22, 2022

These hurdles prevent intact therapeutic mRNAs from accumulating in the body or intended tissue and often trigger an immune response. Intramuscular injection is the most used administration route for vaccination…However, this method has so far been unable to achieve sterile immunity. evade endolysosomal degradation .

Immunity 116

Immunity Immunization Vaccines Hospitals 116

PharmaShots

JANUARY 31, 2023

Shots: Immutable capital demands and high-spending drug development plans are the most common drivers in encouraging fully-fledged private healthcare companies to go public. Founded Year: 2019 No. Founded Year: 2019 No. Funding Value: $230M Founded Year: 2019 No. Funding Value: $7.7M Founded Year: 2021 No.

Vaccines 40

Vaccines Immunization Immunity Diabetes 40

Pharmaceutical Technology

MARCH 2, 2023

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.

Chemotherapy 40

Chemotherapy Vaccines Diabetes Immunity 40

Pharmaceutical Technology

FEBRUARY 20, 2023

On the other hand, a lack of diversity in clinical trial populations, particularly when the disease population is significantly underrepresented, greatly diminishes the quality of data obtained for drug safety and efficacy profiles. This may sound obvious, but it is still a major hurdle in drug development.

Vaccines 52

Vaccines Communication Immunity Immunization 52

Pharmaceutical Technology

AUGUST 1, 2022

AMR occurs when disease-causing bacteria become resistant or immune to the antibiotics used to treat them. million direct deaths in 2019 and an additional 4.95 As a result, many large pharmaceutical firms have dropped out of the market in favour of pursuing more profitable areas of drug development, such as oncology.

Vaccines 93

Vaccines Pharmaceutical Companies Pharmaceutical Companies Chemotherapy 93

STAT

MARCH 6, 2023

“I’m slowly running out of options,” said Young, 62, who in November began   receiving   a five-month series of shots at a clinic near her San Francisco home; the vaccine is designed to teach her immune cells to recognize and combat tumors.

Vaccines 246

Vaccines Bioethics Immunization Immunity 246